Lumazine synthase catalyzes the condensation of 5-amino-6-(D- ribitylamino)-2,4- (1H,3H)pyrimidinedione with the novel carbohydrate, L- 3,4-dihydroxy-2-butanone-4-phosphate to form the immediate precursor of riboflavin, 6,7-dimethyl-8-(D-ribitylamino)lumazine. Recent developments in our understanding of lumazine synthase include the identification of L- 3,4.dihydroxy-2-butanone-4-phosphate as one of the substrates and the 2.4 A X-ray structure of reconstituted (beta-60 capsids of lumazine synthase complexed with phosphate and the substrate analog, 5-nitro-(D- ribitylamino)-2,4-(lH,3H)pyrimidinedione. This new information has opened up new possibilities for the study of the structure and mechanism of lumazine synthase. The identification of the carbohydrate precursor has allowed a mechanistic hypothesis to be advanced concerning the pathway for the conversion of the substrates into the lumazine product. In addition, the X-ray structure has made it possible to propose a mechanism for how the enzyme functions in catalyzing the reaction and a hypothetical binding geometry for the substrates and proposed reaction intermediates. In order to test these new ideas, metabolically stable substrate and reaction intermediate analogs are required. The present research project involves the design and synthesis of a set of lumazine synthase probes that will be valuable in obtaining evidence about the mechanism of the reaction catalyzed by the enzyme. The metabolically stable ligands have been designed to represent certain hypothetical intermediates in the proposed mechanism. After synthesis, they will be bound to the active site of lumazine synthase by ligand driven aggregation or by diffusion and the X- ray structures of the resulting complexes will be determined. In addition, the structures of the complexes will be investigated by REDOR and TENDOR solid state NMR techniques. REDOR NMR offers the advantages of 0.1 resolution and applicability to non-crystalline protein samples, and is therefore complementary to X-ray techniques. The recent identification of L-3,4-dihydroxy-2-butanone-4-phosphate as a substrate of lumazine synthase has also made it possible, for the first time, to determine the standard thermodynamic and kinetic parameters of lumazine synthase inhibitors. The inhibition constants (Ki) and dissociation constants (KD) of the new inhibitors will be determined, arid ligand displacement studies will also be performed. The binding stoichiometry will be determined. These experiments will be performed on both heavy riboflavin synthase as well as on hollow beta-60 capsids obtained by ligand-driven aggregation. Besides variation of the ligands studied, all potential mutations of the protein can be made by site-directed mutagenesis, and the recombinant proteins can be expressed in E. coil. The mechanistic interpretation will be based on protein as well as ligand modification. Uniformly 15N-labeled protein and fluorine-containing protein will be especially useful in the intepretation of the REDOR spectra.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM051469-04
Application #
2749982
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Laughlin, Maren R
Project Start
1995-08-01
Project End
2000-03-31
Budget Start
1998-08-01
Budget End
2000-03-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Purdue University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Talukdar, Arindam; Zhao, Yujie; Lv, Wei et al. (2012) O-Nucleoside, S-nucleoside, and N-nucleoside probes of lumazine synthase and riboflavin synthase. J Org Chem 77:6239-61
Morgunova, Ekaterina; Illarionov, Boris; Saller, Sabine et al. (2010) Structural study and thermodynamic characterization of inhibitor binding to lumazine synthase from Bacillus anthracis. Acta Crystallogr D Biol Crystallogr 66:1001-11
Kim, Ryu-Ryun; Illarionov, Boris; Joshi, Monika et al. (2010) Mechanistic insights on riboflavin synthase inspired by selective binding of the 6,7-dimethyl-8-ribityllumazine exomethylene anion. J Am Chem Soc 132:2983-90
Talukdar, Arindam; Morgunova, Ekaterina; Duan, Jianxin et al. (2010) Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase. Bioorg Med Chem 18:3518-34
Zhao, Yujie; Bacher, Adelbert; Illarionov, Boris et al. (2009) Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis. J Org Chem 74:5297-303
Talukdar, Arindam; Breen, Meghan; Bacher, Adelbert et al. (2009) Discovery and development of a small molecule library with lumazine synthase inhibitory activity. J Org Chem 74:5123-34
Yu, Tsyr-Yan; O'Connor, Robert D; Sivertsen, Astrid C et al. (2008) (15)N{(31)P} REDOR NMR studies of the binding of phosphonate reaction intermediate analogues to Saccharomyces cerevisiae lumazine synthase. Biochemistry 47:13942-51
Zhang, Yanlei; Illarionov, Boris; Morgunova, Ekaterina et al. (2008) A new series of N-[2,4-dioxo-6-d-ribitylamino-1,2,3,4-tetrahydropyrimidin-5-yl]oxalamic acid derivatives as inhibitors of lumazine synthase and riboflavin synthase: design, synthesis, biochemical evaluation, crystallography, and mechanistic implications. J Org Chem 73:2715-24
Zhang, Yanlei; Jin, Guangyi; Illarionov, Boris et al. (2007) A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluation. J Org Chem 72:7176-84
Talukdar, Arindam; Illarionov, Boris; Bacher, Adelbert et al. (2007) Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase. J Org Chem 72:7167-75

Showing the most recent 10 out of 36 publications